secwatch.observer — SEC 8-K summary
======================================

Issuer:     aTYR PHARMA INC (ATYR)
CIK:        0001339970
Form:       8-K
Filed at:   2026-10-16T20:02:31+00:00
Accession:  0001339970-26-000068
Event type: other
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.07
LLM model:  deepseek-v4.1-flash:cloud@v2

aTyr Pharma holders approve reverse stock split of 1-for-10 to 1-for-50 at Board's discretion
--------------------------------------------------------------------------------

- Proposal 1 approved: alternate charter amendments let the Board effect a reverse split at any ratio between 1-for-10 and 1-for-50, inclusive, in its sole discretion.
- Vote tally: 52,451,734 for, 5,234,645 against, 228,991 abstained, no broker non-votes.
- 57,915,370 shares, or about 59.04% of shares outstanding, were represented at the October 16, 2026 Special Meeting.
- Record date was September 4, 2026, with 98,087,425 shares of common stock outstanding and entitled to vote.
- Filing does not state a split ratio, timing, or effective date; those remain subject to future Board determination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1339970/000133997026000068/0001339970-26-000068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1339970/000133997026000068/atyr-20261016.htm
  HTML page:      https://secwatch.observer/filing/0001339970-26-000068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer